US8653068B2ActiveUtilityA1

Filamin A binding anti-inflammatory and analgesic

Assignee: BARBIER LINDSAY BURNSPriority: Oct 30, 2009Filed: Oct 30, 2009Granted: Feb 18, 2014
Est. expiryOct 30, 2029(~3.3 yrs left)· nominal 20-yr term from priority
C07D 498/10A61P 29/00C07D 471/10
91
PatentIndex Score
15
Cited by
19
References
5
Claims

Abstract

A compound or its pharmaceutically acceptable salt, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula A, wherein the R group substituents, d, e, f, k, n, m, D, E, F, K, G, P, Q, W, and Z are defined within.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A compound or its pharmaceutically acceptable salt that corresponds in structure to Formula III, wherein Z is C(O) and Q is CH 2 , 
       
         
           
           
               
               
           
         
         wherein D and F are the same or different and are CH 2 , CH(deuterium) or C(deuterium) 2 , 
         each of m and n is one, 
         W is NR 7 , 
         X is CH 2 , 
         circle A is an aromatic or heteroaromatic ring system containing one ring or two fused rings; 
         R 1  is H, 
         R 2  is C(H) v (deuterium) h  where each of v and h is 0, 1, 2 or 3 and v+h=3, or C(H) q (deuterium) r -aliphatic C 1 -C 5  hydrocarbyl where each of q and r is 0, 1, or 2 and q+r=0, 1 or 2, and 
         R 7  is H. 
       
     
     
       2. The compound or its pharmaceutically acceptable salt according to  claim 1 , wherein said compound corresponds in structure to a formula selected from the group consisting of: 
       
         
           
           
               
               
           
         
       
     
     
       3. A pharmaceutical composition comprising an analgesic effective amount of a compound of  claim 1  dissolved or dispersed in a physiologically tolerable carrier. 
     
     
       4. A compound or its pharmaceutically acceptable salt, wherein said compound corresponds in structure to the formula 
       
         
           
           
               
               
           
         
       
     
     
       5. A compound or its pharmaceutically acceptable salt, wherein said compound corresponds in structure to the formula

Join the waitlist — get patent alerts

Track US8653068B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.